Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2 933,"Ways JA, et al., Physiol Genomics. 2006 Dec 19;.",liver mass,,RS:0000186,COP/OlaHsd,not specified,105 days,15,,CMO:0000633,liver weight to body weight ratio,,,,35.3,g/kg,0.45,1.7428,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,68513,control condition, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",body mass,,RS:0000186,COP/OlaHsd,male,95 days to 89 days,10,,CMO:0001400,maximum body weight loss to initial body weight ratio,,,,3.9,%,1.0,3.1623,MMO:0000016,body weighing method,,0.0,,arterial catheter implantation,1,days,arterial catheter implantation (for 1 days),107173,arterial catheter implantation (for 1 days), 933,"Ways JA, et al., Physiol Genomics. 2006 Dec 19;.",blood triglyceride amount,,RS:0000186,COP/OlaHsd,not specified,105 days,14,,CMO:0000548,plasma triglyceride level,,,,0.584323,mmol/l,0.0938,0.3509,MMO:0000173,spectrophotometry,,0.0,,,,,control condition,68557,control condition, 933,"Ways JA, et al., Physiol Genomics. 2006 Dec 19;.",blood triglyceride amount,,RS:0000186,COP/OlaHsd,not specified,105 days,20,,CMO:0000548,plasma triglyceride level,,,,0.294139,mmol/l,0.0215,0.096,MMO:0000173,spectrophotometry,,0.0,,,,,fasting (for 16 hours),68560,fasting (for 16 hours), 143,"Haag JD, et al., Cancer Res 2003 Sep 15;63(18):5808-12",mammary gland integrity trait,,RS:0000186,COP/OlaHsd,female,160 days to 155 days,16,,CMO:0000343,mammary tumor number,,3X3 mm diameter or larger,,0.25,,0.1,0.4,MMO:0000344,necropsy,,,,,,,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ",11747,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ", 144,"Shull JD, et al., Endocrinology 2001 Dec;142(12):5124-30",mammary gland integrity trait,,RS:0000186,COP/OlaHsd,female,397 days to 271 days,20,,CMO:0000343,mammary tumor number,,,,0.4,,0.1342,0.6,MMO:0000158,manual palpation method,,0,,,,,17 beta-estradiol (27.5 mg) (between 212 and 330 days),11753,17 beta-estradiol (27.5 mg) (between 212 and 330 days), 933,"Ways JA, et al., Physiol Genomics. 2006 Dec 19;.",heart left ventricle mass,,RS:0000186,COP/OlaHsd,not specified,105 days,15,,CMO:0000071,heart left ventricle wet weight,,,,0.49,g,0.01,0.0387,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,68497,control condition, 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",arterial blood pressure trait,Initial MAP,RS:0000186,COP/OlaHsd,male,95 days to 89 days,10,,CMO:0000009,mean arterial blood pressure,,,,121,mmHg,3.0,9.4868,MMO:0000013,vascular fluid filled catheter,,300.0,5-second intervals,,,,arterial catheter implantation (for 1 days),107331,arterial catheter implantation (for 1 days), 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",erythrocyte quantity,"initial hematocrit, final hematocrit, change in hematocrit",RS:0000186,COP/OlaHsd,male,95 days to 89 days,10,,CMO:0000037,hematocrit,,,,36.9,%,1.7,5.3759,MMO:0000215,microhematocrit tube assay with visual assessment,,0.0,,,,,arterial catheter implantation (for 1 days),107234,arterial catheter implantation (for 1 days), 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",erythrocyte quantity,"initial hematocrit, final hematocrit, change in hematocrit",RS:0000186,COP/OlaHsd,male,95 days to 89 days,10,,CMO:0000037,hematocrit,,,,29.7,%,1.1,3.4785,MMO:0000215,microhematocrit tube assay with visual assessment,,0.0,,,,,arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours),107251,arterial catheter implantation (for 1 days),controlled hemorrhage (between 1 and 6 hours) 345,"Lee SJ, et al., Physiol Genomics 2005 Jul 20;.",heart mass,,RS:0000186,COP/OlaHsd,male,105 days,4,,CMO:0000069,heart wet weight,,,,0.5668,g,,,MMO:0000005,post excision weight measurement,,0.0,,,,,running on inclined treadmill (10 m/min) (for 0.1 hours),13337,running on inclined treadmill (10 m/min) (for 0.1 hours), 345,"Lee SJ, et al., Physiol Genomics 2005 Jul 20;.",heart mass,,RS:0000186,COP/OlaHsd,male,105 days,4,,CMO:0000074,heart weight to body weight ratio,,,,2.17,g/kg,,,MMO:0000005,post excision weight measurement,,0.0,,,,,running on inclined treadmill (10 m/min) (for 0.1 hours),13339,running on inclined treadmill (10 m/min) (for 0.1 hours), 933,"Ways JA, et al., Physiol Genomics. 2006 Dec 19;.",heart mass,,RS:0000186,COP/OlaHsd,not specified,105 days,15,,CMO:0000074,heart weight to body weight ratio,,,,2.76,g/kg,0.03,0.1162,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,68525,control condition, 933,"Ways JA, et al., Physiol Genomics. 2006 Dec 19;.",heart left ventricle mass,,RS:0000186,COP/OlaHsd,not specified,105 days,15,,CMO:0000530,heart left ventricle weight to body weight ratio,,,,1.75,mg/g,0.02,0.0775,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,68517,control condition, 933,"Ways JA, et al., Physiol Genomics. 2006 Dec 19;.",liver mass,,RS:0000186,COP/OlaHsd,not specified,105 days,15,,CMO:0000158,liver wet weight,,,,9.55,g,0.16,0.6197,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,68493,control condition, 933,"Ways JA, et al., Physiol Genomics. 2006 Dec 19;.",abdominal fat pad mass,,RS:0000186,COP/OlaHsd,not specified,105 days,15,,CMO:0000088,abdominal fat pad weight,,,,4.95,g,0.22,0.8521,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,69253,control condition, 933,"Ways JA, et al., Physiol Genomics. 2006 Dec 19;.",kidney mass,,RS:0000186,COP/OlaHsd,not specified,105 days,15,,CMO:0000340,both kidneys wet weight to body weight ratio,,,,6.8,g/kg,0.14,0.5422,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,68521,control condition, 933,"Ways JA, et al., Physiol Genomics. 2006 Dec 19;.",blood glucose amount,,RS:0000186,COP/OlaHsd,not specified,105 days,20,,CMO:0000042,plasma glucose level,,,,119.2,mg/dl,4.34,19.4091,MMO:0000165,blood glucose test strip read by electrochemical glucometer,,0.0,,,,,fasting (for 16 hours),68569,fasting (for 16 hours), 144,"Shull JD, et al., Endocrinology 2001 Dec;142(12):5124-30",mammary gland integrity trait,,RS:0000186,COP/OlaHsd,female,330 days to 212 days,7,,CMO:0000345,post-insult time to mammary tumor formation,,mean,,208,d,7.5593,20.0,MMO:0000158,manual palpation method,,,,,,,17 beta-estradiol (27.5 mg) (between 212 and 330 days),11749,17 beta-estradiol (27.5 mg) (between 212 and 330 days), 144,"Shull JD, et al., Endocrinology 2001 Dec;142(12):5124-30",mammary gland integrity trait,,RS:0000186,COP/OlaHsd,female,330 days to 212 days,7,,CMO:0000345,post-insult time to mammary tumor formation,,median,median,195,d,,,MMO:0000158,manual palpation method,,,,,,,17 beta-estradiol (27.5 mg) (between 212 and 330 days),11751,17 beta-estradiol (27.5 mg) (between 212 and 330 days), 933,"Ways JA, et al., Physiol Genomics. 2006 Dec 19;.",heart mass,,RS:0000186,COP/OlaHsd,not specified,105 days,15,,CMO:0000069,heart wet weight,,,,0.76,g,0.01,0.0387,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,68505,control condition, 933,"Ways JA, et al., Physiol Genomics. 2006 Dec 19;.",kidney mass,,RS:0000186,COP/OlaHsd,not specified,105 days,15,,CMO:0000085,both kidneys wet weight,,,,1.84,g,0.05,0.1936,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,68501,control condition, 345,"Lee SJ, et al., Physiol Genomics 2005 Jul 20;.",body mass,,RS:0000186,COP/OlaHsd,male,105 days,4,,CMO:0000012,body weight,,,,260.5,g,,,MMO:0000016,body weighing method,,0.0,,,,,running on inclined treadmill (10 m/min) (for 0.1 hours),13335,running on inclined treadmill (10 m/min) (for 0.1 hours), 144,"Shull JD, et al., Endocrinology 2001 Dec;142(12):5124-30",mammary gland integrity trait,,RS:0000186,COP/OlaHsd,female,330 days to 212 days,7,,CMO:0000948,percentage of study population developing mammary tumors during a period of time,,mean,,43.8,%,,,MMO:0000158,manual palpation method,,0,,,,,17 beta-estradiol (27.5 mg) (between 212 and 330 days),66113,17 beta-estradiol (27.5 mg) (between 212 and 330 days), 933,"Ways JA, et al., Physiol Genomics. 2006 Dec 19;.",pancreas mass,,RS:0000186,COP/OlaHsd,not specified,105 days,15,,CMO:0000626,pancreas wet weight,,,,0.62,g,0.03,0.1162,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,68489,control condition, 933,"Ways JA, et al., Physiol Genomics. 2006 Dec 19;.",pancreas mass,,RS:0000186,COP/OlaHsd,not specified,105 days,15,,CMO:0000630,pancreas weight to body weight ratio,,mg/g,,2.29,mg/g,0.12,0.4648,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,68509,control condition, 933,"Ways JA, et al., Physiol Genomics. 2006 Dec 19;.",blood insulin amount,,RS:0000186,COP/OlaHsd,not specified,105 days,10,,CMO:0000342,plasma insulin level,,,,29.12,mU/l,5.72,18.0882,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting (for 16 hours),68572,fasting (for 16 hours), 933,"Ways JA, et al., Physiol Genomics. 2006 Dec 19;.",body mass,,RS:0000186,COP/OlaHsd,not specified,105 days,15,,CMO:0000012,body weight,,,,271,g,5.5,21.3014,MMO:0000016,body weighing method,,0.0,,,,,control condition,68485,control condition, 932,"Ways JA, et al., Genomics 2002 Jul;80(1):13-20.",body mass,,RS:0000186,COP/OlaHsd,male,84 days to 77 days,N/A,,CMO:0000012,body weight,,,,228,g,7.0,,MMO:0000016,body weighing method,,,timing method,,,,control condition,84622,control condition, 933,"Ways JA, et al., Physiol Genomics. 2006 Dec 19;.",blood free fatty acid amount,,RS:0000186,COP/OlaHsd,not specified,105 days,14,,CMO:0000546,plasma free fatty acids level,,,,0.12,mmol/l,0.01,0.0374,MMO:0000173,spectrophotometry,,0.0,,,,,control condition,68563,control condition, 933,"Ways JA, et al., Physiol Genomics. 2006 Dec 19;.",blood free fatty acid amount,,RS:0000186,COP/OlaHsd,not specified,105 days,20,,CMO:0000546,plasma free fatty acids level,,,,0.23,mmol/l,0.02,0.0894,MMO:0000173,spectrophotometry,,0.0,,,,,fasting (for 16 hours),68566,fasting (for 16 hours), 933,"Ways JA, et al., Physiol Genomics. 2006 Dec 19;.",exercise endurance trait,,RS:0000186,COP/OlaHsd,male,77 days,15,,CMO:0001406,maximum distance run on treadmill,,mg/g,,571.9,m,27.5,106.507,MMO:0000362,treadmill method with electric shock source,,0.0,,,,,running on treadmill (10 m/min) ,69245,running on treadmill (10 m/min) , 933,"Ways JA, et al., Physiol Genomics. 2006 Dec 19;.",exercise endurance trait,,RS:0000186,COP/OlaHsd,male,77 days,15,,CMO:0001406,maximum distance run on treadmill,,mg/g,geometric mean,406.2,m,17.2,66.6153,MMO:0000362,treadmill method with electric shock source,,0.0,,,,,running on treadmill (10 m/min) ,69249,running on treadmill (10 m/min) , 932,"Ways JA, et al., Genomics 2002 Jul;80(1):13-20.",exercise endurance trait,,RS:0000186,COP/OlaHsd,male,84 days to 77 days,N/A,,CMO:0001406,maximum distance run on treadmill,,,,345,m,17.0,,MMO:0000382,treadmill method with electric shock source and automated tracking,,0.0,timing method,,,,running on inclined treadmill (10 m/min) ,68477,running on inclined treadmill (10 m/min) , 345,"Lee SJ, et al., Physiol Genomics 2005 Jul 20;.",exercise endurance trait,,RS:0000186,COP/OlaHsd,male,82 days to 77 days,4,,CMO:0001406,maximum distance run on treadmill,,maximum distance run on treadmill,,392,m,,,MMO:0000382,treadmill method with electric shock source and automated tracking,,0.0,with pedometer/odometer,,,,running on inclined treadmill (10 m/min) (for 0.1 hours),68084,running on inclined treadmill (10 m/min) (for 0.1 hours), 933,"Ways JA, et al., Physiol Genomics. 2006 Dec 19;.",subcutaneous adipose mass,,RS:0000186,COP/OlaHsd,not specified,105 days,15,,CMO:0002069,abdominal subcutaneous fat pad weight,,,,1.27,g,0.11,0.426,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,69255,control condition, 932,"Ways JA, et al., Genomics 2002 Jul;80(1):13-20.",exercise endurance trait,,RS:0000186,COP/OlaHsd,male,84 days to 77 days,N/A,,CMO:0002306,maximum time spent running to exhaustion on treadmill,,time spent running maximum distance on treadmill,,22.7,min,1.0,,MMO:0000382,treadmill method with electric shock source and automated tracking,,0.0,timing method,,,,running on inclined treadmill (10 m/min) ,68478,running on inclined treadmill (10 m/min) , 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",eating behavior trait,Food consumed (g) postsurgery per 100 g BW,RS:0000186,COP/OlaHsd,male,95 days to 89 days,10,,CMO:0002214,food intake weight to body weight ratio,,,,5.1,g/d/100g,0.4,1.2649,MMO:0000620,food intake measuring method,,0.0,,arterial catheter implantation,1,days,arterial catheter implantation (for 1 days),107140,arterial catheter implantation (for 1 days), 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",drinking behavior trait,Water consumed (g) postsurgery per 100 g BW,RS:0000186,COP/OlaHsd,male,95 days to 89 days,10,,CMO:0002859,water intake drink rate to body weight ratio,,,,0.47,ml/d/kg,0.08,0.253,MMO:0000619,drink intake measuring method,,0.0,,arterial catheter implantation,1,days,arterial catheter implantation (for 1 days),107156,arterial catheter implantation (for 1 days), 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",blood amount,,RS:0000186,COP/OlaHsd,male,95 days to 89 days,10,,CMO:0003663,volume of blood removed to total prehemorrhagic blood volume ratio,5.83 mL/100 g of body weight,,,57.1,%,0.4,1.2649,MMO:0000016,body weighing method,,,,,,,arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours),109125,arterial catheter implantation (for 1 days),controlled hemorrhage (between 1 and 6 hours) 3077,"Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53.",erythrocyte quantity,"initial hematocrit, final hematocrit, change in hematocrit",RS:0000186,COP/OlaHsd,male,95 days to 89 days,10,,CMO:0002538,absolute change in hematocrit,,,,8.9,%,1.0,3.1623,MMO:0000215,microhematocrit tube assay with visual assessment,,0.0,,,,,arterial catheter implantation (for 1 days) then controlled hemorrhage (between 1 and 6 hours),107267,arterial catheter implantation (for 1 days),controlled hemorrhage (between 1 and 6 hours)